FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen (Heisenberg-Professur)
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology
Lehrstuhl für Innere Medizin I
Overview
Publications
(254)
Research Grants
(3)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Hobit- and Blimp1-driven tissue resident memory T cells critically control chronic intestinal inflammation (2018)
Zundler S, Becker E, Spocinska M, Parga-Vidal L, Stark R, Atreya R, Rath T, et al.
Conference contribution
IL-3 drives IL-10-secreting Tr1 cells to counteract experimental colitis (2018)
Zundler S, Spocinska M, Popp V, Becker E, Atreya R, Neufert C, Atreya I, et al.
Conference contribution
Clinical efficacy of the Toll-like receptor 9 agonist cobitolimod using patient-reported-outcomes defined clinical endpoints in patients with ulcerative colitis (2018)
Atreya R, Reinisch W, Peyrin-Biroulet L, Scaldaferri F, Admyre C, Knittel T, Kowalski J, et al.
Journal article
Crohn's Disease: Improved Treatment by Treat-to-Target-Concept Comment (2018)
Atreya R
Journal article
Development of Reliable, Valid and Responsive Scoring Systems for Endoscopy and Histology in Animal Models for Inflammatory Bowel Disease (2018)
Koelink PJ, Wildenberg ME, Stitt LW, Feagan BG, Koldijk M, Van 'T Wout AB, Atreya R, et al.
Journal article
Clinical outcomes and immunogenicity analysis over 6 months following a switch from originator infliximab (Remicade (R)) to the biosimilar SB2 (Flixabi (R)) in inflammatory bowel disease patients (2018)
Fischer SM, Klenske E, Schmitt H, Vitali F, Hirschmann S, Koch F, Ramming A, et al.
Conference contribution
Alpha 4 beta 7 Integrin-dependent gut homing of non-classical monocytes is essential for intestinal wound healing mediated by M2 macrophages (2018)
Schleier L, Wiendl M, Binder MT, Atreya R, Watson A, Neufert C, Atreya I, et al.
Conference contribution
The TLR9 agonist cobitolimod induces anti-inflammatory effects and balances the Th17/T-reg cell response in ulcerative colitis (2018)
Schmitt H, Billmeier U, Ulmschneider J, Admyre C, Knittel T, Zargari A, Neurath M, Atreya R
Conference contribution
IBD IN 2017 Development of therapy for and prediction of IBD - getting personal (2018)
Atreya R, Siegmund B
Journal article
A comparative analysis of articular bone in large cohort of patients with chronic inflammatory diseases of the joints, the gut and the skin (2018)
Simon D, Kleyer A, Englbrecht M, Stemmler F, Simon C, Berlin A, Kocijan R, et al.
Journal article
‹
1
...
16
17
18
19
20
...
25
›